Navigation Links
Barr Receives Tentative Approval for a Generic Version of Mirapex(R) Tablets, 0.125mg, 0.25mg, 0.5mg, 1mg and 1.5mg
Date:10/30/2007

WOODCLIFF LAKE, N.J., Oct. 30 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL) today announced that its subsidiary, Barr Laboratories, Inc., has received tentative approval from the U.S. Food and Drug Administration (FDA) for its generic version of Boehringer Ingelheim Pharmaceuticals, Inc.'s Mirapex(R) (Pramipexole Dihydrochloride) Tablets, 0.125mg, 0.25mg, 0.5mg, 1mg and 1.5mg. The Company believes that it is the first to file an Abbreviated New Drug Application (ANDA) with a paragraph IV certification for Mirapex.

Barr filed its Abbreviated New Drug Application (ANDA) for generic Mirapex Tablets, 0.25mg containing a paragraph IV certification with the FDA in May 2005 and in June 2005 amended its application to include the tablet strengths 0.125mg, 0.5mg, 1mg, and 1.5mg. The Company received notification of the application's acceptance for filing in July 2005. Following receipt of the notice from the FDA, Barr notified Boehringer Ingelheim, the New Drug Application (NDA) holder and patent owner. On September 26, 2005, Boehringer Ingelheim filed suit in the U.S. District Court in Delaware to prevent Barr from proceeding with the commercialization of its product, formally initiating the patent challenge process under the Hatch-Waxman Act.

Although trial of the case had been scheduled for November 5, 2007, due to a judicial vacancy in the District Court, the trial is not expected to commence then. A new trial date has not been set. The 30-month stay expires on or about February 15, 2008.

Mirapex(R) (Pramipexole Dihydrochloride) tablets are indicated for the treatment of the signs and symptoms of idiopathic Parkinson's disease. The product had annual sales of approximately $324 million f
'/>"/>

SOURCE Barr Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Infant receives first bloodless liver transplant
2. British MPs Say Prostate Cancer Receives Low Priority in the NHS
3. Fifth US Patient Receives Artificial Heart
4. Northfield Labs Receives FDA Comments
5. Abbott Receives CE Mark Certification
6. Zactima Receives Fast Track Designation By The FDA
7. East London Receives World Class New Private Hospital Facility
8. Brinda Karat Receives Legal Notice over Ramdev Issue
9. Quake-Hit Pakistan Receives 30 Field Hospitals From Cuba
10. Medtronic’s Insulin Pump Receives Regulatory Approva
11. Aurobindo Receives Approval from USFDA for anti-AIDS drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... Jersey (PRWEB) May 05, 2015 Horizon ... maintained its strong and secure credit rating of “A” ... Horizon BCBSNJ’s financials last week, the Wall Street ratings ... and “leading market position” in determining the rating and ... mind is one of our top priorities, so we ...
(Date:5/5/2015)... New York (PRWEB) May 05, 2015 ... ( http://www.testosteronelawsuithub.com/ ) filed on behalf of ... due to their use of prescription testosterone ... the federal multidistrict litigation underway in U.S. ... to court documents dated May 1st, defendants ...
(Date:5/5/2015)... Sunny skies and cool temperatures made for great conditions ... and walkers participated in Global Lyme Alliance’s (GLA) inaugural ... The 5K and 10K runs and 1-and 3-mile walks were ... funds for tick-borne disease research. The “Lyme Walk and Run” ... of Lyme Research Alliance (LRA) and Tick-Borne Disease Alliance ...
(Date:5/5/2015)... In a April 25, 2015, report published ... the Missouri State Highway Patrol (MSHP) announced that Indiana led ... for the second year in a row. , The ... 1,469 incidents in 2014 alone, around 15% of the national ... the US Population calls Indiana home, according to the report. ...
(Date:5/5/2015)... The brains of people with type 1 ... slower information processing, according to research led by the ... . , The findings indicate that clinicians should ... cognitive difficulties. If progressive, these changes could influence their ... the National Institutes of Health (NIH), is ...
Breaking Medicine News(10 mins):Health News:Horizon Blue Cross Blue Shield of New Jersey Maintains “A” Credit Rating from Standard & Poor’s 2Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 2Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 3Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 4Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 2Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 3Health News:A Forever Recovery Releases New Information on the Epidemic Rise Of Methamphetamine Abuse in Midwest America 2Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 2Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 3Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 4
... by a jackal in Bihar's Gopalganj district, but there are ... patients. ,In the last two days, ... and children - in half a dozen villages under the ... ,The injured are being treated at different hospitals ...
... bio-technology pharma company from Zurich, Switzerland has developed a ... months at a time . ,The drug ... blood pressure by contracting vessels, by inducing antibodies. ... CYT006-AngQb developed by Cytos Biotechnology reduced systolic blood pressure ...
... in that US doctors tend to prescribe unwanted, even possibly ... the name of lecture assignments. ,Lawmakers are ... to disclose payments made to doctors and also keep within ... earn more money from drug makers than doctors in any ...
... heiress Paris Hilton under house arrest, has defended his ... from a 'life-threatening' psychiatric condition called decompensating. ... mental state to the point of severe depression, nervousness ... Simple Life star's condition was even more complicated because ...
... Louis University has found that a patient's emotional state plays ... surgery. ,After hip surgery, two tests are ... is a clinical measure of hip function given by the ... considers a wide variety of factors in determining the overall ...
... at the University of York and Hull York Medical School ... folate. ,Folate is a vitamin that comes ... and peas. Fortified cereal products, sunflower seeds as well as ... been claiming that adding folate to bread or flour will ...
Cached Medicine News:Health News:US Lawmakers Considering Legislation to Restrict Payments by Drug Companies to Doctors 2Health News:US Lawmakers Considering Legislation to Restrict Payments by Drug Companies to Doctors 3Health News:Emotions Play 'significant Role' in Recovery from Hip Surgery 2
(Date:5/5/2015)... 2015 Ardelyx, Inc. (NASDAQ: ARDX ... gastrointestinal, and metabolic diseases, today announced that a ... Stage 3 chronic kidney disease patients with type ... the primary endpoint of decreasing the urinary albumin-creatinine ... placebo. Ardelyx formed a partnership ...
(Date:5/5/2015)... -- (Family Features) Which health screenings and exams are ... monitoring your weight, cholesterol, and blood pressure is probably ... vision care? Photo - http://photos.prnewswire.com/prnh/20150505/213909 ... they often start to notice small changes in their ... performance. Whether having difficulty reading a book or working ...
(Date:5/5/2015)... , May 05, 2015 Research and Markets ... addition of the "Electro Surgical Market" ... electrosurgical market is expected to achieve a CAGR ... surgery offer huge benefits for patients as well ... surgery infections, condensed visible marks, bleeding control and ...
Breaking Medicine Technology:Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 2Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 3Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 4Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 5Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 6Eye Care as You Age 2Eye Care as You Age 3Eye Care as You Age 4Global Electro Surgical Market 2015 2
... ATLANTA, Nov. 9, 2010 Today, UCB, Inc. celebrates ... Scholarship recipients.  Over the past 6 years, UCB has ... to people whose lives have been directly affected by ... members.  Epilepsy is a common neurological condition that can ...
... Inc. (Nasdaq: ONXX ) today announced the ... proteasome inhibitor, at the American Society of Hematology (ASH) ... Convention Center in Orlando, FL. "The ... treatment option for patients with multiple myeloma, and we ...
Cached Medicine Technology:Biopharma Company UCB Unveils 40 Deserving 2010 Family Epilepsy Scholarship Recipients 2Biopharma Company UCB Unveils 40 Deserving 2010 Family Epilepsy Scholarship Recipients 3Onyx Pharmaceuticals Announces Data Presentations Highlighting Carfilzomib Development Program at 52nd American Society of Hematology Annual Meeting 2Onyx Pharmaceuticals Announces Data Presentations Highlighting Carfilzomib Development Program at 52nd American Society of Hematology Annual Meeting 3Onyx Pharmaceuticals Announces Data Presentations Highlighting Carfilzomib Development Program at 52nd American Society of Hematology Annual Meeting 4Onyx Pharmaceuticals Announces Data Presentations Highlighting Carfilzomib Development Program at 52nd American Society of Hematology Annual Meeting 5
The Lineage acetabular system with UHMWPE liners provide lipped options for increased femoral head coverage promoting a stable joint....
Hemisphere modular Cup....
Link All-Poly acetabular cups for cement....
Metal on metal hip acetabular cups available for both cemented and cementless applications, the Biomet Merck metal on metal articulation hip system (M2aTM) combines proven materials with the latest i...
Medicine Products: